References
- Jensen MK, de Nully Brown P, Nielsen OJ, Hasselbalch HC. Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area. Eur J Haematol 2000;65:132–139
- Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A. Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc 2006;81:159–166
- Chow CC, Shah RJ, Lim JI, Chau FY, Hallak JA, Vajaranant TS. Peripapillary retinal nerve fiber layer thickness in sickle-cell hemoglobinopathies using spectral-domain optical coherence tomography. Am J Ophthalmol 2013;155:456–464
- van Dijk HW, Verbraak FD, Kok PH, Garvin MK, Sonka M, Lee K, et al. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Invest Ophthalmol Vis Sci 2010;51:3660–3665
- Takahashi H, Chihara E. Impact of diabetic retinopathy on quantitative retinal nerve fiber layer measurement and glaucoma screening. Invest Ophthalmol Vis Sci 2008;49:687–692
- Leung CK, Tham CC, Mohammed S, Li EY, Chan WM, Lam DS. In vivo measurements of macular and nerve fibre layer thickness in retinal arterial occlusion. Eye (Lond) 2007;21:1464–1468
- Alasil T, Wang K, Keane PA, Lee H, Baniasadi N, de Boer JF, et al. Analysis of normal retinal nerve fiber layer thickness by age, sex, and race using spectral domain optical coherence tomography. J Glaucoma 2013;22:532–541
- Richard S, Perrin J, Baillot PA, Laccour JC, Ducrocg X. Ischaemic stroke and essential thrombocythemia: a series of 14 cases. Eur J Neurol 2011;18:995–998
- Mignon I, Grand F, Boyer F, Hunault-Berger M, Hamel JF, Macchi L. Thrombin generation and procoagulant phospholipids in patients with essential thrombocythemia and reactive thrombocytosis. Am J Hematol. 2013;88:1007--1011. doi: 10.1002/ajh.23553
- Labauge R, Pagès M, Labauge P. Neurologic complications of essential thrombocythemia.6 cases. Rev Neurol (Paris) 1991;147:52–56
- Fenaux P, Simon M, Caulier MT, Lai JL, Goudemand J, Bauters F. Clinical course of essential thrombocythemia in 147 cases. Cancer 1990;66:549–556
- Regev A, Stark P, Blickstein D, Lahav M. Thrombotic complications in essential thrombocythemia with relatively low platelet counts. Am J Hematol 1997;56:168–172
- Michiels JJ, Koudstaal PJ, Mulder AH, van Vliet HH. Transient neurologic and ocular manifestations in primary thrombocythemia. Neurology 1993;43:1107–1110
- Imasawa M, Iijima H. Multiple retinal vein occlusions in essential thrombocythemia. Am J Ophthalmol 2002;133:152–155
- Nobacht S, Cruysberg JR, Deutman AF. Peripheral retinal nonperfusion associated with essential thrombocytosis. Am J Ophthalmol 1999;127:101–102
- Yoshizumi MO, Townsend-Pico W. Essential thrombocythemia and central retinal vein occlusion with neovascular glaucoma. Am J Ophthalmol 1996;121:728–730
- Liu M, Lee AG, Rice L, Lambert HM. Bilateral retinal vascular occlusive disease in essential thrombocythemia. Retina 1999;19:563–564
- Sørensen TL, Mortzos P. Iritis, ptosis, and sequential severe loss of vision in a patient with essential thrombocytosis. Eye (Lond) 2010;24:928
- Seibold LK, Mandava N, Kahook MY. Comparison of retinal nerve fiber layer thickness in normal eyes using time-domain and spectral-domain optical coherence tomography. Am J Ophthalmol 2010;150:807–814